Session 1 Flashcards

1
Q

Define hypersensitivity

A

“the antigen specific immune responses that are either inappropriate or excessive and result in harm to host”. The mechanisms underlying these aberrant immune responses are those employed by the host to fight infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the types of triggers (antigens) that cause hypersensitivity reactions?

A

• Hypersensitivity to exogenous antigens: 

Non infectious substances (innocuous) 

Infectious microbes 

Drugs (E.g. Penicillin)

• Hypersensitivity to intrinsic antigens: 

Infectious microbes (mimicry) 

Self antigens (auto-immunity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the types of hypersensitivity reaction?

A
  • Type I or immediate (Allergy) - IgE
  • Environmental non infectious antigens
  • Type II or antiBody mediated - IgG or IgM but mainly IgG - Against membrane bound antigens so often organ specific.
  • Type III or immune Complexes mediated - IgG or IgM but mainly IgG - soluble antigen complex circulates in blood and where it deposits, is where disease will present.
  • Type IV or cell mediated (Delayed) 
  • Environmental infectious agents and self antigens

Types I, II, and III are antibody mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the common features of hypersensitivity reaction?

A

All hypersensitivity types have these phases

• Sensitization phase 

First encounter with the antigen. Activation of Antigen Presenting Cells and memory effector cells. A previously exposed individual to the antigen is said to be “sensitized”

• Effector phase 

Pathologic reaction upon re-exposure to the same antigen and activation of the memory cells of the adaptive immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe type II hypersensitivity reactions

A
  • Usually develops within 5-12 hr ftere xposure
  • Involves IgG (mostly) or IgM antibodies
  • Targets cell bound antigens:
  • Exogenous: Blood group antigens, Rhesus D antigens
  • Endogenous: self antigens
  • Induces different outcomes:
  • Tissue/cell damage
  • Physiological change - change in function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the mechanisms of type 2 hypersensitivity reactions

A

Antibodies recognise antigen on cell leading to complement activation which will drive the membrane attack complex which will punch holes in the cell membrane leading to cell lysis

The other way through which these cells will be killed via complement activation is through neutrophil recruitment/ activation (C3a/C5a) and then opsonisation (C3b) which will cause the neutrophils to kill the target cells

Examples of this are haemolytic disease of the newborn (HDN) - Antigen = Rhesus D and Transfusion reactions - Antigen= ABO system

The other way cells will be killed is through antibody-dependent cell cytotoxicity (NK cells)

  • Autoimmune haemolytic anaemia (warm and cold) - antibody to red blood cells.
  • Immune thrombocytopenia - antibody to platelets - Purpura
  • Goodpasture’s syndrome - antibody against basement membrane of glomerula leading to glomerular nephritis

Physiological change:

Receptor stimulation

• Graves’ disease − Increased thyroid activity − Antigen = TSH receptor

Receptor blockade

• Myasthenia gravis − Impaired neuromuscular signalling − Antigen = Acetylcholine receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give an example of disease caused by type II hypersensitivity (IgM) and describe its immune mechanism

A

Haemolytic transfusion reaction

  • Life-threatening condition
  • Shock, kidney failure, circulatory collapse, and death Immune mechanism

Mechanism:

  • Incompatibility in the ABO or rhesus D antigens
  • Donor RBC destroyed by recipient’s immune system
  • RBC lysis induced by type II hypersensitivity involving by the naturally occurring antibodies (IgM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the therapeutic approaches to type II hypersensitivity reactions

A

To deal with Tissue/Cell damage

  • Anti-inflammatory drugs - associated with bad side effects.
  • Prevents complement activation
  • Plasmapheresis
  • Remove circulating antibodies and inflammatory mediators
  • Splenectomy
  • Reduces Opsonisation/Phagocytosis when patient has autoimmune haemolytic anaemia or immune thrombocytopenia (patient )
  • Intravenous immunoglobulin (IVIG)
  • Causes IgG degradation

To do with physiological change

  • Correct metabolism
  • Antithyroid drugs in Graves’s disease or thyroidectomy
  • Replacement therapy
  • Pyridostigmine in Myasthenia gravis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Plasmapheresis therapy?

A

Plasma is removed and filtered to remove antibodies.

Used to treat Myasthenia gravis, Goodpasture’s syndrome and Graves’ disease

Short term relief and allows healing of damaged tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe Type III hypersensitivity

A
  • Usually develops within 3-8 hr
  • Involves immune complexes between IgG or IgM and antigens
  • Targets soluble antigens 
  • Foreign (Infection) 
  • Endogenous (self antigens)

• Tissue damage caused by the deposition of immune complexes in host tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key factors affecting intracellular pathogenesis in type III hypersensitivity reactions?

A

• Complex size 

  • Small and large size immune complexes cleared 
  • Intermediate size immune complexes harder to remove

• Host response 

  • Low affinity antibody favour intermediate size immune complexes
  • Complement deficiency causes type 3 hypersensitivity. Opsonisation allows large immune complexes to bind to red blood cells so that they can be taken to the liver but withoutcomplement this is not possible.

Persistence of IC deposition causes multisystem disease

  • Joint
  • Kidney
  • Small vessels
  • Skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does the body remove immune complexes?

A

Large complexes are opsonised and then attach to red blood cells where they are then taken to the liver to be disposed of.

Intermediate sized immune complexes are deposited in tissues activate complement which starts opsonising the tissue which attracts neurtorphils which go on to damage the tissue.

Small immune complexes macrophages/monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give 3 examples of diseases caused by type III hypersensitivity reactions

A

Rheumatoid arthritis (self-antigen) - symmetrical peripheral inflammatory arthritis

  • Antigen = Fc portion of IgG (75%)
  • Articular and extra-articular features
  • Episodes of inflammation/remission
  • Poor prognosis factors 
  • <30 year-old 
  • High-titre of Rheumatoid factor which is the antibody against Fc portion of IgG 
  • Female 
  • DR4 allele 
  • Joint erosions

Glomerulonephritis (infectious)

Caused by:

  • Bacterial endocarditis
  • Hepatitis B infection

(they cause long term systemic production of the microbe which tends to cause intermediate immune complex production which end up in the kidney)

Systemic lupus erythematosus

  • Antigen = Double stranded-DNA
  • Most prevalent immune complexes disease
  • Ratio female:male (9:1)
  • 40-60% patients with cardiac, respiratory, renal, joint and neurological features
  • Repeated miscarriage
  • Every patient is unique
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe type IV hypersensitivity reactions

A
  • Usually develops within 24-72hr
  • Involves lymphocytes and macrophages
  • Different subtypes (clinical outcomes)
  • Contact hypersensitivity
  • Tuberculin hypersensitivity
  • Granulomatous hypersensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the mechanisms of tissue destruction in type IV hypersensitivity reactions?

A

Antigen presenting cells and macrophages in the sensitisation phase trigger a T cell response (TH1 response) so activate CD8 and cytotoxic T lymphocytes.

In the effector phase the TH1 will remmeber the microbe and so macrophages will be activated which will recruit more TH1 at the site and go onto form a granuloma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give 3 examples of diseases caused by type IV hypersensitivity to exogenous antigens

A

Contact hypersensitivity (contact dematitis)

  • Occurs 48-72 hr post exposure
  • Epidermal reaction
  • Require endogenous proteins to ilicit reaction.
  • Examples:
  • o Nickel - cancause production an endogenous protein
  • o Poison ivy
  • o Organic chemicals

Treated with immunosuppressants but that can leave cavitation

Granulomatous hypersensitivity

  • Occurs 21-48 days post-exposure
  • Tissue damage
  • Examples:

o Tuberculosis

o Leprosy (tuberculoid)

o Schistosomiasis

o Sarcoidosis

Tuberculin hypersensitivity - test for TB

Causes local swelling and redening after test.

Occurs 48-72hr

Dermal reaction

17
Q

Give 3 examples of Diseases caused by Type IV hypersensitivity to endogenous antigens

A

• Pancreatic Islet cells:

o Insulin-dependent diabetes mellitus

• Thyroid gland:

o Hashimoto’s thyroiditis

• Fc portion of IgG:

o Rheumatoid arthritis

18
Q

Compare Hashimoto’s disease versus Graves’ disease

A

Hashimoto’s disease involves immune destruction of the thyroid gland by tissue infiltration of CD4+/CD8+ T cells and is a type IV hypersensitivity reaction which leads to hypothyroidism. Treatment is giving atient lifelong thyroxine.

Grave’s disease is a physiological increase in thyroid function caused by a type II hypersensitivity reaction as antibodies bind to TSH receptors and stimulate thyroid cells causing hyperthyroidism. Treatment is anti thyroid medication, plasmapheresis or thyroidectomy in order of commonality.

19
Q

Describe the therapy for Type III and IV hypersensitivity

A

Anti-inflammatory drugs

  • Non-steroidals
  • Corticosteroids (oral prednisolone)
  • Second drugs as steroid-sparing agents (<10 mg oral steroid) 
  • Azathioprine 
  • Mycophenolate mofetil 
  • Cyclophosphamide

Monoclonal antibodies

  • B Cells and T cells
  • Cytokine network
  • Antigen presenting cells
20
Q

What is type I hypersensitivity?

A

Type I hypersensitivity = Allergy

• Immunological basis for different diseases

o Different organs affected - where IgE and mast cells are activated

• Immediate reaction (<30min)

o Local reaction : Ingested or inhaled allergen

o Systemic reaction: Insect sting or IV administration

• Antigens (allergens)

o Environmental, non-infectious antigens (proteins)

21
Q

Examples of allergens for type 1 hypersensitivity

A

• Seasonal exposure

o Tree and grass pollens

• Perennial exposure (throughout the year)

o House dust mite

o Animal dander = cats and dogs

o Fungal spores

• Accidental exposure

o Insect venom (wasp and bee stings)

o Medicines - for example, the antibiotic penicillin

o Chemicals such as latex

o Foods: milk, peanuts, nuts, etc…

22
Q

Describe the mechanisms of type I hypersensitivity

A

• Abnormal adaptive immune response against the allergens (normal response is TH1 which produces IgG which doesnt activate mast cells.)

o T helper 2 (TH2) response (IL-4, IL-5, IL-13)

o IgE production

• Mast cell activation

o Sensitized individuals

o Different clinical allergic disorders depending of on mast cell location

23
Q

How does allergy prevalence differ between developing and westernized countries?

A

If you live in a developing country you are less likely to have an allergy compared to that of somone living in a westernized country. This is due to the hygiene hypothesis, where the the less infectious burden the more likely allergy is to develop.

24
Q

Why do people have allergies?

A
25
Q

What is the hygiene hypothesis?

A

• Children exposed to animals, pets and microbes in the early postnatal period appear to be protected against certain allergic diseases 

26
Q

What is the “Old friends hypothesis” or “biodiversity hypothesis”?

A

The western lifestyle is associated with microbial dysbiosis

• Western lifestyle induces alteration of the symbiotic relationships with parasites and bacteria leading to “dysbiosis” of the microbiome at mucosal surfaces (gut) 

Dysbiosis = compositional and functional alterations of microbiome 

Microbiome = The complete genetic content of all the microorganisms that typically inhabit in the body, such as the skin or the gastrointestinal tract.

Picture of baby refers to C section birth.

27
Q

Origin of mast cells and tissue distribution

A

Mast cells produced by bone marrow. Progenitor enters blood and matures in the tissue and you can tell it has matured by the presence of the FcϵR1 receptor and this is where the IgE will bind. Mature due to stem cell factor/

Strategic location:

  • Most mucosal and epithelial tissues = gastrointestinal tract, skin, respiratory epithelium
  • In connective tissue surrounding blood cells

Effeicient against parastitc infections which these areas are commonly attacked by.

28
Q

Name some mast cell mediators, the class of product they belong to and their biological effects

A

Tryptase - Enzyme - Remodel connective tissue matrix

Histamine - Toxic mediator - Toxic to parasites, increase vascular permeability, cause smooth muscle contraction

Leukotrienes, C4, D4,E4 - Lipid mediator - cause smooth muscle contraction, increase vascular permeability, stimulate mucus secretion

Platelet-activating factor - Lipid mediator - Attracts leukocytes, amplifies production of lipid mediators, activates neutrophils, eosinophils and platelets

29
Q

Describe the immune mechanism of allergic reaction

A

First exposure will drive a TH2 response and produce IgE against the allergen which will bind against the FcϵRI receptor of the mast cell. The Ige will bind systemically to all mast cells arming them ready for next exposure. In the subsequnt exposure, after sensitization, the allergen will crosslink to the IgE bound to the mast cell in a process called IgE cross linking. which will then activate the mast cell causing it to degranulate. This will happen wherever the mast cells are activated, so if you only have a local exposure then you will have a local response but if you have a systemic exposure you will have systemic response.

Mast cells are mostly present in the muscos membranes and blood vessels so in the vessels you will have increased vascular permeability, vasodialtion and lose some blood volume. If activated in the lungs you will have brocnhoconstriction.There can aslo be mast cell activation in the heart.

30
Q

How does an allergic reaction manisfest in the skin?

A

Urticaria

Characerised by wheals (white, raised and itchy area) and flares (erythetamous area caused by vasodilation)

Caused by mast cell activation within the epidermis

Mediators = Histamine and leukotrienes/cytokines

If prolonged and chronic exposure you will end up with atopic dermatitis and eczema

31
Q

How does an allergic reaction manifest in the face?

A

Angioedema

Non-itchy swelling

Caused by mast cell activation in the deep dermis.

Mediators = Histamine and bradykinin

Lip, eyes, tongue and upper respiratory airways can all be affected

If aiways affected, it can be life threatening.

32
Q

Systemic manifestations of allergic reaction: anaphylaxis

A

Defined as acute onset, rapid proression allergic response with skin involvement and one otherorgan system. Or if someone has a history of anaphylaxis, acuteonset, rapid progression allergic response with bronchoconstriction, hypotension or severe GI problem.

Systemic activation of mast cells causing systemic response.

Life threatening, needs immediate treatment.

Patient loses 30% of blood voume in first 10 minutes.

Can hear wheeze and stridor on lung auscultation.

33
Q

What are the signs and symptoms of anaphylaxis?

A
34
Q

What is the treatment of anaphylactic shock?

A

epinephrine (adrenaline) IM

  • Reverses peripheral vasodilation and reduces oedema and alleviates hypotension by acting on alpha 1 receptors.
  • Reverses airway obstruction / bronchospasm by acting on beta 2 receptor in lung.
  • Increases the force of myocardial contraction by acting on beta 1 receptors of heart.
  • Inhibits mast cell activation

DO NOT DELAY TREATMENT!!!! Monitor pulse, blood pressure, ECG, oximetry

Key points about epinephrine therapy:

  • Timesaver vs lifesaver - still need to call emergncy services, In 20/30% of anaphylaxis is biphasic so will come back.
  • IM vs SC administration - IM is much better
  • Multiple doses may be required as can be biphasic
  • Proper use of epipen important
35
Q

Other allergic mediated diseases?

A
36
Q

Therapy for type I hypersensitivity?

A

• Abnormal adaptive immune response against the allergens

o TH2 response = Allergen desensitization (oral immunotherapy)

o IgE = Anti-IgE monoclonal antibody, good against chronic urticaria and asthma.

• Mast cell activation

o Anti-histamine

o Leukotriene receptor antagonists

o Corticosteroids

37
Q

What is allergen desensitization or immunotherapy?

A

Definition:

“It involves the administration of increasing doses of allergen extracts over a period of years, given to patients by injection or drops/tablets under the tongue (sublingual)”

90% effective in patients with bee and wasp venom anaphylaxis

Oral option upcoming as potential better option.

Potential mechanisms:

  • CD4+CD25 Regulatory T cells
  • Shift from TH2 to TH1
  • Inhibitory anti-inflammatory cytokines
  • Allergen specific blocking IgG
38
Q

What is the most common cause of immunodeficiency?

A

Malnutrition

39
Q

What is the difference between IgG and IgM antibodies?

A

IgG is the most abundant type of antibody, is found in all body fluids and protects against bacterial and viral infections. Immunoglobulin M (IgM), is very large in comparison and so is found mainly in the blood and lymph fluid, is the first antibody to be made by the body to fight a new infection.IgM cannot cross the placenta during pregnancy.